Graham Center One-Pager

Medicare Part D: Who Wins, Who Loses?



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2006 Feb 1;73(3):401.

  Related Editorial

The Medicare Part D prescription drug benefit aims to relieve the burden of out-of-pocket prescription drug costs for persons older than 65 years, but its effects will vary. Persons with low income and those without prior prescription coverage are projected to save the most, whereas those who lose employer-based coverage are predicted to pay more for their existing regimens.

Medicare Part D, although providing some welcome relief for older patients with high prescription costs, has a complex design reflecting significant political compromise.1 Enrollees continue to share prescription costs with Medicare through a series of mechanisms, including an enrollment premium of $32 per month; a deductible of $250 per year; a coinsurance between $250 and $2,250 per year, for which enrollees pay 25 percent of drug costs; a “doughnut hole” between $2,250 and $5,100 per year, for which enrollees are responsible for 100 percent; and a catastrophic cap of $5,100 per year, above which enrollees pay 5 percent (costs reflect 2006 estimates).2 Low-income enrollees with limited assets, if concomitantly registered for subsidies through the Social Security Administration, have nearly complete coverage with elimination of premiums, deductibles, coinsurance, and doughnut holes.

Of the 43 million eligible Medicare beneficiaries, an estimated 29 million will participate by the end of 2006.2 Although most will enroll voluntarily, more than 7 million patients with Medicare and Medicaid dual eligibility or other low-income assistance will be signed up automatically.2 On average, participants’ out-of-pocket costs will decrease by 37 percent under Part D—from $1,257 to $792—at a cost of $724 billion to the federal treasury over the next 10 years.3 However, for some beneficiaries, out-of-pocket spending will increase.

Who will benefit most? Medicare beneficiaries with no prior drug coverage (approximately one in four) will see their average annual costs cut in half, from more than $1,500 to $780.2 Low-income beneficiaries (those at less than 150 percent of the federal poverty level) will see their average annual expenses reduced by 83 percent, or $584. Low-income enrollees who previously were without Medicaid will spend an estimated $1,400 less per year. However, close to 40 percent of low-income beneficiaries are unlikely to sign up for subsidies.2

Who will face increased spending? An estimated 7 million beneficiaries will see an average annual increase in spending of $492 (see accompanying figure)2; a large portion of these will be retirees who lose employer coverage.2 Despite tax-free subsidies from Medicare, 17 to 35 percent of employers are expected to drop their prescription coverage, which typically is more comprehensive than that offered through Part D.3

Effect of Medicare Part D on Spending

Figure.

Estimated effect of Medicare Part D on participants’ spending.

Information from reference 2.

View Large

Effect of Medicare Part D on Spending


Figure.

Estimated effect of Medicare Part D on participants’ spending.

Information from reference 2.

Effect of Medicare Part D on Spending


Figure.

Estimated effect of Medicare Part D on participants’ spending.

Information from reference 2.

Physicians should encourage Part D enrollment among patients who will benefit most, while recognizing that up to 35 percent of enrollees may have no relief or an increase in their out-of-pocket expenses for prescription medications.

REFERENCES

1. Rosenthal MB. Doughnut-hole economics. Health Aff. 2004;23:129–35.

2. Estimates of Medicare beneficiaries’ out-of-pocket drug spending in 2006. Menlo Park, Calif.: Actuarial Research Corporation and The Henry J. Kaiser Family Foundation, 2004.

3. Stuart B, Briesacher BA, Shea DG, Cooper B, Baysac FS, Limcangco MR. Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit. Health Aff. 2005;24:1022–31.

note: The information and opinions contained in research from the Graham Center do not necessarily reflect the views or the policy of the AAFP.

Adapted from the Graham Center One-Pager #41. Mallya G, Bazemore AW, Phillips RL, Green LA, Klein LS, Dodoo MS. Medicare Part D: who wins, who loses? February 2006.Available online at http://www.graham-center.org/onepager41.xml. From the Robert Graham Center: Policy Studies in Family Medicine and Primary Care, 1350 Connecticut Ave., NW, Suite 201, Washington, DC 20036 (telephone: 202–331–3360; fax: 202–331–3374; e-mail: policy@aafp.org).

 


Copyright © 2006 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in Pubmed

Navigate this Article